Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study
Krishna Susarla, Sai, Jahagirdar, Rahul, Ghosh Uttam, Kheya, Srikanth Bhatt, S., Prashanth, S., Rajapantula, Vasudev, Satish, M., Rajashakar, B.C., Sandhya, G., Rajendra, L., Prasad Sahoo, Devi, Kumar Kanakasapapathy, Anand
Published in Vaccine (20.10.2023)
Published in Vaccine (20.10.2023)
Get full text
Journal Article
Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study
Susarla, Sai Krishna, Palkar, Sonali, SV, Pardha Saradhi, Diwan, Arundhati, Barsode, Supriya, Satish, M., Rajashakar, BC, Sandhya, G., Lingala, Rajendra, Sahoo, Devi Prasad
Published in Vaccine (08.04.2021)
Published in Vaccine (08.04.2021)
Get full text
Journal Article
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6–8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study
Susarla, Sai Krishna, Gupta, Madhu, Mantan, Mukta, Dhongade, Ramchandra, Bhave, Sheila, Das, Rajat Kumar, Ray, Rajib Kumar, Ramesh Babu, T., Ravi, M.D., Krishnamurthy, B., James, Saji, Sandhya, G., Satish, M., Sahoo, Devi Prasad
Published in Vaccine (23.08.2019)
Published in Vaccine (23.08.2019)
Get full text
Journal Article
A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age
Susarla, Sai Krishna, Narang, Manish, Khandgave, Prashant Namdev, Patnaik, Lipilekha, Rajapantula, Vasudev, M, Satish, Bc, Rajashakar, Sahoo, Devi Prasad, Kanakasapapathy, Anand Kumar
Published in Infectious diseases (London, England) (08.10.2024)
Published in Infectious diseases (London, England) (08.10.2024)
Get more information
Journal Article
Immunogenicity and safety of Havisure TM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Susarla, Sai Krishna, Gupta, Madhu, Kheya Ghosh Uttam, Palkar, Sonali, Dhongade, Ashish Ramachandra, K Siva Ram Prasad, Vasudev Rajapantula, Ravi, MD, Pradeep, N, Satish, M, Rajashakar, B C, Sandhya, G, Rajendra, L, Devi Prasad Sahoo, Kanakasapapathy, Anand Kumar
Published in Vaccine (06.10.2023)
Published in Vaccine (06.10.2023)
Get full text
Journal Article
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Susarla, Sai Krishna, Gupta, Madhu, Uttam, Kheya Ghosh, Palkar, Sonali, Dhongade, Ashish Ramachandra, Siva Ram Prasad, K., Rajapantula, Vasudev, Ravi, M.D., Pradeep, N., Satish, M., Rajashakar, B.C., Sandhya, G., Rajendra, L., Sahoo, Devi Prasad, Kanakasapapathy, Anand Kumar
Published in Vaccine (06.10.2023)
Published in Vaccine (06.10.2023)
Get full text
Journal Article
Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naïve patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India
Kuila, Nivedita, Dash, Nilima, Sahoo, Devi Prasad, Pattnayak, Naresh Chandra, Biswas, Ghanashyam, Chakraborty, Soumen
Published in Leukemia & lymphoma (01.01.2009)
Published in Leukemia & lymphoma (01.01.2009)
Get full text
Journal Article
EVI1, BAALC and AME: Prevalence of the secondary mutations in chronic and accelerated phases of chronic myeloid leukemia patients from eastern India
Kuila, Nivedita, Sahoo, Devi Prasad, Kumari, Meera, Biswas, Sutapa, Patnaik, Ravi Sekhar, Pattnayak, Naresh Chandra, Biswas, Ghanashyam, Chakraborty, Soumen
Published in Leukemia research (01.04.2009)
Published in Leukemia research (01.04.2009)
Get full text
Journal Article